A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

The first report to compare what pharmaceutical companies are doing to bring antimicrobial resistance under control. By highlighting where good ideas are being implemented, it encourages their wider uptake.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Overall ranking Vacancies Funding Methodology Key Finding

In the media

Read how the global media covers how pharmaceutical companies respond to market trends and global health issues using the Foundation's research, and translates the complexity of access to medicine for the public.

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

27 Dec 2014

2014 Index findings in the Pharmaceutical Journal

The Pharmaceutical Journal in London creates an infographic of a range of findings from the 2014 Access to Medicine Index, including insights into the...

01 Dec 2014

Leaders, risers and fallers in the 2014 Index covered by the NYT

Donald McNeil reports GSK’s No.1 position, also noting that more than half of the companies in the 2014 Index are developing paediatric formulations o...

21 Nov 2014

Die Welt covers 2014 Index in series of online and print articles

Anja Ettel discusses progress made by the pharmaceutical industry while also highlighting the question of corruption, in a series of four online and p...

18 Nov 2014

BMJ reports that progress is being made, but struggles remain – 2014 Index

The British Medical Journal reports that the finding that top drug companies are making drugs more accessible but are also struggling to perform in th...

17 Nov 2014

NOS reports that pharma companies are active on behalf of 3rd world – 2014 Index

Dutch public broadcaster, the NOS, publishes the 2014 ranking while reporting on the positive efforts being made by pharmaceutical companies to increa...

17 Nov 2014

Economic Times of India covers the 2014 Index

The Economic Times of India reports on how the efforts pharmaceutical companies are making to improve access, are undermined by corruption incidences.

17 Nov 2014

PharmaTimes reports on pharma industry progress and struggles as revealed by 2014 Index

Kevin Grogran writes about where pharmaceutical companies are doing well, and where progress remains static, as revealed by the 2014 Access to Medicin...

17 Nov 2014

De Volkskrant covers 2014 Index, noting shift from philanthropy to business

In his coverage of the 2014 Index, Sander Heijne notes the observation that pharmaceutical companies are doing more to make medicine accessible in dev...

17 Nov 2014

Reuters balances industry progress with Policy finding in 2014 Index coverage

Ben Hirschler from Reuters covered the 2014 Index in depth, concluding that the world’s top drugmakers have improved access to medicines in developing...

Got a question?

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.